41363-00-2 Usage
General Description
7-Amino-5,6,7,8-tetrahydro-naphthalen-2-ol is a chemical compound that belongs to the class of naphthalen-2-ol derivatives. It is a white to off-white solid with a molecular formula of C10H13NO and a molecular weight of 163.22 g/mol. 7-AMINO-5,6,7,8-TETRAHYDRO-NAPHTHALEN-2-OL is used in various industries, including pharmaceuticals, agrochemicals, and material science, for its application as a building block in the synthesis of other chemical compounds. It is also used as a reagent in organic synthesis and as a raw material for the production of various products. The chemical properties and structure of 7-amino-5,6,7,8-tetrahydro-naphthalen-2-ol make it a versatile and valuable compound in the field of chemistry and related industries.
Check Digit Verification of cas no
The CAS Registry Mumber 41363-00-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,1,3,6 and 3 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 41363-00:
(7*4)+(6*1)+(5*3)+(4*6)+(3*3)+(2*0)+(1*0)=82
82 % 10 = 2
So 41363-00-2 is a valid CAS Registry Number.
InChI:InChI=1S/C10H13NO/c11-9-3-1-7-2-4-10(12)6-8(7)5-9/h2,4,6,9,12H,1,3,5,11H2
41363-00-2Relevant articles and documents
INDOLE AHR INHIBITORS AND USES THEREOF
-
Paragraph 00644-00645, (2018/11/22)
The present invention provides compounds useful as inhibitors of AHR, compositions thereof, and methods of using the same.
Aryloxypropanolaminotetralins, a process for their preparation and pharmaceutical compositions containing them
-
, (2008/06/13)
Aryloxypropanolaminotetralins with beta-antagonist activity of the formula STR1 wherein R is hydrogen, hydroxy or methoxy and Ar is an optionally substituted aromatic or heteroaromatic group, in optically active or inactive form as well as their acid addition salts are described.A process for their preparation and pharmaceutical compositions containing the compounds of formula (i) or their pharmaceutically acceptable acid addition salts, are also described.
